MedPath

Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma

Recruiting
Conditions
Monocytes
Multiple Myeloma
CART Cells
Registration Number
NCT07180992
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Tumoral micro-environment in malignant haematological diseases, notably in multiple myeloma, is active on plasma cells survival and proliferation. Monocytosis and monocytes typing are described in multiple myeloma response as factors on proliferation and cell death evasion. CART cells have improved multiple myeloma care in last 5 years, nethertheless, early relapse occur and we must identify predictor factors of better response. The aim of this study is to analyze basic level and phenotyping of monocytes before and after CART cells infusion and study their impact on multiple myeloma response

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Patients over 18 years old
  • Treated for a multiple myeloma
  • CART cells treatment proposed
  • Affiliated to social security system
  • Agreed to participate to the study
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
overall response rateday 1
Secondary Outcome Measures
NameTimeMethod
Progression free survival3 years
Overall survival3 years
time to next treatment3 years

Trial Locations

Locations (1)

CHRU Amiens

🇫🇷

Amiens, France

CHRU Amiens
🇫🇷Amiens, France
Lydia Montes, MD
Contact
33+322088371
Montes.lydia@chu-amiens.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.